Babycell, a cord blood banking company and Neogen Labs, one of the prominent centers in screening Inborn Errors of Metabolism (IEM) announced a strategic tie up to bring world class health care to the newborns through Newborn Screening tests.
Babycell will leverage its experience and expertise to enhance the range and quality of health care services through cord blood banking. With these enhancements Babycell is expected to be well positioned to cater to the changing health care needs of the people all over India.
Newborn screening is the practice of testing every newborn with a single drop of dried blood for certain harmful or potentially irreversible Inborn Errors of Metabolism that is not otherwise apparent at birth. Worldwide four lakh babies affected by IEMs and 20 per cent suffer with mental retardation which is avoidable if IEM done on time which make the difference between lifelong impairment and healthy development.
Commenting on the development, Yash Sanghavi, chairman and CEO, Babycell said, "In order to create focused services, the company is providing the newborn screening tests. It is a moment of great pride as we cross another milestone on the path of our evolution and today we have successfully positioned ourselves as a true biotechnology company.”
Babycell is the only ISO: 13485 accredited cord blood banking company in India approved by the Indian FDA and DCGI, Babycell services to all the major cities in India including Mumbai, Pune, Hyderabad, Delhi NCR, Bangalore, Ahmadabad, Chennai and Kolkata.
RMS Regrow is a leading biotechnology company in India, focused on advanced cell therapy treatments and cord blood banking. Through their cell processing centre (CPC) – the only one in India, RMS Regrow offers autologous cartilage and bone cell therapeutics to patients. Babycell is the stem cell banking division of RMS Regrow. RMS Regrow aims at applying regenerative medicines to bring effective patient specific therapeutics to bed side. The treatments are now available at various hospitals across India.